Is REAER a new therapy for people with multiple sclerosis?

News

Аvera Allen, Deputy Editor In Chief

Date: 04.06.2021

A team of multiple sclerosis (MS) experts at Kessler Foundation led the first pilot randomized controlled trial of robotic-exoskeleton assisted exercise rehabilitation (REAER) effects on mobility, cognition, and brain connectivity in people with substantial MS-related disability.

Their results showed that REAER is likely an effective intervention, and is a promising therapy for improving the lives of those with MS.

It is common for people with MS to experience impairments in both mobility and cognition, and few therapies exist to manage the range of debilitating symptoms. This lack of treatment options is a major problem for people with MS, especially those with substantial MS-related neurological disability.

Previous research shows that exercise rehabilitation, such as walking, is an effective approach to symptom management, with some research suggesting that even a single exercise rehabilitation intervention can improve both mobility and cognition.

Rehabilitation exercise using robotic exoskeletons is a relatively new approach that enables participants to walk over-ground in a progressive regimen that involves close engagement with a therapist. The Foundation has dedicated a Ekso NR to MS studies to facilitate further research in this area.

By Аvera Allen | Linkedin

#News #Health #Medical #KesslerFoundation #Whealthnews

Views: 12

Leave a request

Select option
Thank you, application submitted.